Open Access

[Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway

  • Authors:
    • Lishuai Xu
    • Weidong Li
    • Qian Shi
    • Minfeng Wang
    • Heng Li
    • Xiaoli Yang
    • Junjun Zhang
  • View Affiliations

  • Published online on: August 18, 2022     https://doi.org/10.3892/or.2022.8389
  • Article Number: 174
  • Copyright : © Xu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

October-2022
Volume 48 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Xu L, Li W, Shi Q, Wang M, Li H, Yang X and Zhang J: [Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting <em>HDAC9</em> and deactivating the PI3K/AKT pathway. Oncol Rep 48: 174, 2022
APA
Xu, L., Li, W., Shi, Q., Wang, M., Li, H., Yang, X., & Zhang, J. (2022). [Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting <em>HDAC9</em> and deactivating the PI3K/AKT pathway. Oncology Reports, 48, 174. https://doi.org/10.3892/or.2022.8389
MLA
Xu, L., Li, W., Shi, Q., Wang, M., Li, H., Yang, X., Zhang, J."[Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting <em>HDAC9</em> and deactivating the PI3K/AKT pathway". Oncology Reports 48.4 (2022): 174.
Chicago
Xu, L., Li, W., Shi, Q., Wang, M., Li, H., Yang, X., Zhang, J."[Retracted] MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting <em>HDAC9</em> and deactivating the PI3K/AKT pathway". Oncology Reports 48, no. 4 (2022): 174. https://doi.org/10.3892/or.2022.8389